Speciality: Oncology
Description:
Dr. Sushant Mittal kicked off the insightful session titled "CNS Clarity from Day One: Rethinking Early Diagnostic Strategies", joined by esteemed panelists Dr. Tarachand Gupta and Dr. Randeep Singh. The discussion opened with a strong emphasis on the clinical importance of early evaluation for central nervous system (CNS) involvement, especially in complex or aggressive disease presentations. Dr. Mittal highlighted how delays in CNS assessment can result in mismanagement or missed therapeutic windows, setting the tone for a thought-provoking exchange. Dr. Gupta and Dr. Singh added their expertise from neurology and oncology perspectives, offering valuable multidisciplinary insights.
The session explored how CNS evaluation at the time of initial diagnosis is gaining traction in clinical protocols. With advancements in neuroimaging, cerebrospinal fluid analysis, and molecular biomarkers, early detection of CNS disease has become more achievable and actionable. The panel discussed real-world challenges in integrating these strategies, including resource constraints and variability in presentation. Emphasis was placed on identifying high-risk patients early - particularly in oncology and infectious disease contexts - where CNS involvement can significantly affect prognosis and treatment pathways. The conversation also touched on the need for standardized screening protocols and decision-making frameworks that support clinicians across specialties.
Thank you to all who joined this informative session. Your engagement and curiosity continue to drive these meaningful conversations forward. Special thanks to Dr. Sushant Mittal, Dr. Tarachand Gupta, and Dr. Randeep Singh for sharing their expertise. Keep following us for more sessions focused on innovation, interdisciplinary practice, and cutting-edge strategies in healthcare. Together, we’re reshaping how diseases are diagnosed and managed - starting from day one.
See More Webinars @ Hidoc Webinars
1.
Study identifies new target for obesity-related breast cancer
2.
AMA President-Elect Confronts a New Challenge: A Brain Tumor
3.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
4.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
5.
Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers
1.
Strategic Concepts in Hematology for Modern Medicine
2.
Is AI The New Radiologist For Breast MRI?
3.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
4.
Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer
5.
Prognostic Patterns of Functional Recovery During Long-Term Cancer Survivorship
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Blood Clotting Disorders Explained
2.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
5.
Hands-on Workshop: Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation